Life Sciences

Our expertise

Quality, personalisation and risk management

Quality, personalisation and risk management

Our Group is a leading investor in biotechnology and medical devices. We arrange financing and assist with the development of companies and their products through the proof of concept trial stage and sales. Our Life Sciences team’s know-how is a source of value creation for the companies and our clients.

What defines us

The specialisation of our Life Sciences team

  • A very dedicated team

    The Life Sciences team has eight dedicated employees. It is deeply involved with its investments, which take significant holdings of 15% to 25% of capital for a period of two to six years. It also has a consistent presence on company boards.

    To date, our teams have invested in over 50 companies, leading to the creation of more than 2,000 jobs. The companies have brought a dozen new medical products and devices to market, which are now available to patients. Four generations of funds have been launched on this theme.

  • Three targeted and well-managed sectors

    ​We primarily invest in European companies active in therapeutic products, medical equipment and devices and molecular diagnostics. We focus on developing products that are in the preclinical study or prototype stage through proof of effectiveness in humans or early sales.

  • The right answers for start-ups

    ​We meet the needs of pharmaceutical and biotechnology start-ups with well-suited financial arrangements. We are involved as an active partner in company strategy and operational (recruiting, networking) and financial (initial public offerings and industrial sales) implementation. We also assist executives with capital operations (for example, external growth).

Contact us

Matthieu Vercruysse
11-13 rue Jean Fischbach
L-3372 Leudelange

+352 26 74 22 60